Renal injury from valproic acid: Case report and literature review

Pediatric Neurology

Volumn 27, Issue 4, 2002, Pages 318-319

  Zaki, Emad L ^a   Springate, James E ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; GABAPENTIN; PHENOBARBITAL; PHOSPHATE; VALPROIC ACID;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DISEASE COURSE; EPILEPSY; FANCONI RENOTUBULAR SYNDROME; FEMALE; HUMAN; KIDNEY PROXIMAL TUBULE; LABORATORY TEST; PRIORITY JOURNAL; SCHOOL CHILD; SUPPLEMENTATION; TREATMENT OUTCOME; URINALYSIS;

CHILD; EPILEPSY, ABSENCE; FANCONI SYNDROME; FEMALE; HUMANS; KIDNEY; VALPROIC ACID;

EID: 0036810287     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(02)00447-2     Document Type: Article

References (15)

1. Foreman J. Cystinosis and Fanconi syndrome. Barratt T., Avner E., Harmon W., Pediatric nephrology. 1999;593-605 Lippincott Williams & Wilkins, Baltimore.
2. Lenoir G., Perignon J., Gubler M., Broyer M. Valproic acid A possible cause of proximal tubular renal syndrome . J Pediatr. 98:1981;503-504.
3. Hawkins E., Brewer E. Renal toxicity induced by valproic acid. Pediatr Pathol. 13:1993;863-868.
4. Lande M., Kim M., Bartlett C., Guay-Woodford L. Reversible Fanconi syndrome associated with valproate therapy. J Pediatr. 123:1993;320-322.
5. Smith G., Balfe J., Kooh S. Anticonvulsants as a cause of Fanconi syndrome. Nephrol Dial Transplant. 10:1995;543-545.
6. Fukuda Y., Watanabe H., Ohtomo Y., Yahuta K. Immunologically mediated chronic tubulointerstitial nephritis caused by valproate therapy. Nephron. 72:1996;328-329.
7. Altunbasak S., Yildizdas D., Anarat A., Burgut H. Renal tubular dysfunction in epileptic children on valproic acid therapy. Pediatr Nephrol. 16:2001;256-259.
8. Csathy L., Olah A., Clemens B., Gyorgy I., Varga J. Urinary N-acetyl-β-D-glucosaminidase in epileptic children treated with antiepileptic drug. Arch Dis Child. 83:2000;420-422.
9. Verotti A., Greco R., Pascarella R., Matera V., Morgese G., Chiarelli F. Renal tubular function in patients receiving anticonvulsant therapy. Epilepsia. 41:2000;1432-1435.
10. Korinthenberg R., Sager J., Zimmerhackl L. Increased urinary excretion of tubular enzymes and proteins in children with epilepsy. Eur J Paediatr Neurol. 4:2000;263-267.
11. Barakat A. Conditions and syndromes associated with renal abnormalities. Barakat A., Renal disease in children. 1990;455-487 Springer-Verlag, New York.
12. Graf R., Gossrau R., Herker H., Schwabe R., Stahlmann R., Nau H. Enzyme cytochemistry combined with electron microscopy, pharmacokinetics and clinical chemistry for the evaluation of the effects of steady state valproic acid concentrations on the mouse. Histochemistry. 83:1985;347-358.
13. Raza M., Al-Bekairi, Ageel A., Qureshi S. Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder Time dependence of peroxidative injury . Pharmacol Res. 35:1997;153-157.
14. Martin G., Drozard D., Besson J., Baverel G. Effect of the antiepileptic drug sodium valproate on glutamine metabolism in isolated human kidney tubules. Biochim Biophys Acta. 1033:1990;261-266.
15. Zagryadskaya E., Ostretsova I., Nikiforov A. Inhibitory effect of valproate on weak organic acid uptake in rat renal proximal tubules. Biochem Pharmacol. 58:1999;1371-1377.